Barbara Bispham currently serves as SVP and General Counsel at Sail Biomedicines, following the merger of Senda Biosciences and LARONDE in October 2023. Prior to this role, Barbara held positions at BridgeBio as VP and Head of Legal, and at Goodwin as an associate in the Business Law Department within the Tech & Life Sciences group. Barbara's earlier experience includes working as an associate at Cooley LLP in public and emerging companies, and starting their career as an associate at Reed Smith LLP in Hong Kong. Educational credentials include a Juris Doctor from Cornell Law School and a Bachelor of Arts from the University of Pennsylvania, where magna cum laude honors were achieved.
Sign up to view 1 direct report
Get started